Since its founding in 2008, the team at Seventh Sense has been driven by a vision of making healthcare monitoring and diagnostics as intuitive and simple as possible. Seventh Sense is well positioned for the future of the $50 billion in vitro diagnostic industry, which is facing several powerful and potentially conflicting trends - increased demand for efficiency, decentralization of testing and treatment, and engaged healthcare consumers.
With the collaboration of our extraordinary scientific founders, who bring unparalleled expertise in the areas of skin physiology, skin/device interface, and novel assay development, Seventh Sense is creating a unique "On Vivo™" blood sampling and testing platform. This platform is the foundation for a robust pipeline of proprietary products and partnering opportunities across healthcare market segments, including therapeutics, diagnostics, and consumer health.